Literature DB >> 8611188

The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus.

A K Foulis1.   

Abstract

Type 1 diabetes is an organ-specific autoimmune disease in which the insulin-secreting B cell is destroyed. Both genetic factors (linked to class II MHC genes) and environmental agents (viruses, diet) appear to be involved in the aetiology. Study of autopsy pancreases of children who die at presentation of their disease has proved elucidating. In such pancreases islets before, during and after B cell destruction, are all visible. The earliest defined immunological event in the disease process appears to be expression of interferon-alpha by insulin-containing B cells. Secretion of this cytokine is associated with hyperexpression of class I MHC by all the endocrine cells within insulin-containing islets. Another immunological phenomenon which is unique to type I diabetes is the presence of aberrant class II MHC molecule expression by B cells. This may induce autoimmunity by allowing antigen presentation of B cell specific antigens. If the onset of the disease process is marked by interferon-alpha expression by B cells then a search for the presence of a continuing viral infection in these cells may prove profitable, although no viruses have been found in them to date.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611188     DOI: 10.1111/j.1699-0463.1996.tb00702.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2010-06-09       Impact factor: 10.122

2.  Analysis of pancreas tissue in a child positive for islet cell antibodies.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; K Vuori; P Karhunen; C Vasama-Nolvi; S Oikarinen; C Verbeke; G E Blair; I Rantala; J Ilonen; O Simell; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

Review 3.  Enterovirus infection and type 1 diabetes: unraveling the crime scene.

Authors:  T Rodriguez-Calvo
Journal:  Clin Exp Immunol       Date:  2018-11-13       Impact factor: 4.330

Review 4.  The pancreas in human type 1 diabetes.

Authors:  Patrick A Rowe; Martha L Campbell-Thompson; Desmond A Schatz; Mark A Atkinson
Journal:  Semin Immunopathol       Date:  2010-05-22       Impact factor: 9.623

Review 5.  Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment.

Authors:  Brittney N Newby; Clayton E Mathews
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-14       Impact factor: 5.555

6.  An important step towards a prevascularized islet microencapsulation device: in vivo prevascularization by combination of mesenchymal stem cells on micropatterned membranes.

Authors:  Milou Groot Nibbelink; Katarzyna Skrzypek; Lisanne Karbaat; Sanne Both; Jacqueline Plass; Bettie Klomphaar; Jéré van Lente; Sieger Henke; Marcel Karperien; Dimitrios Stamatialis; Aart van Apeldoorn
Journal:  J Mater Sci Mater Med       Date:  2018-11-09       Impact factor: 3.896

7.  Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.

Authors:  Sarah J Richardson; Teresa Rodriguez-Calvo; Ivan C Gerling; Clayton E Mathews; John S Kaddis; Mark A Russell; Marie Zeissler; Pia Leete; Lars Krogvold; Knut Dahl-Jørgensen; Matthias von Herrath; Alberto Pugliese; Mark A Atkinson; Noel G Morgan
Journal:  Diabetologia       Date:  2016-08-09       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.